5-FU Metabolism in Cancer and Orally-Administrable 5-FU Drugs

Koh Miura, Makoto Kinouchi, Kazuyuki Ishida, +9

Cancers

Medicinal ChemistryContinuous Intravenous InfusionOncologyOral 5-Fu Drugs5-Fu Metabolism +11

Comparison of the bone regeneration ability between stem cells from human exfoliated deciduous teeth, human dental pulp stem cells and human bone marrow mesenchymal stem cells

Kengo Nakajima, Ryo Kunimatsu, Kazuyo Ando, +11

Biochemical and Biophysical Research Communications

Regenerative MedicineTissue EngineeringDevelopmental BiologyEngineeringDental Regeneration +9

Periostin Directly and Indirectly Promotes Tumor Lymphangiogenesis of Head and Neck Cancer

Yasusei Kudo, Shinji Iizuka, Maki Yoshida, +12

PLoS ONE

EGFR Regulates the Hippo pathway by promoting the tyrosine phosphorylation of MOB1

Toshinori Ando, Nadia Arang, Zhiyong Wang, +7

Communications Biology

Down‐regulation of cIAP2 enhances 5‐FU sensitivity through the apoptotic pathway in human colon cancer cells

Hideaki Karasawa, Koh Miura, Wataru Fujibuchi, +11

Cancer Science

Metformin Inhibits Progression of Head and Neck Squamous Cell Carcinoma by Acting Directly on Carcinoma-Initiating Cells

Xingyu Wu, Huwate Yeerna, Yusuke Goto, +10

Cancer Research

Nuclear Survivin expression is correlated with malignant behaviors of head and neck cancer together with Aurora-B

Guangying Qi, Yasusei Kudo, Toshinori Ando, +7

Oral Oncology

Tumor BiologyNeck CancerMalignant DiseaseMedicinePathology +9

Infection with Porphyromonas gingivalis Exacerbates Endothelial Injury in Obese Mice

Min Ao, Mutsumi Miyauchi, Toshihiro Inubushi, +9

PLoS ONE

Tissue inhibitor of metalloproteinase-1 promotes cell proliferation through YAP/TAZ activation in cancer

Toshinori Ando, Dyshafilia Charindra, Madhu Shrestha, +4

Oncogene

Yap/taz ActivationTumor BiologyMetalloproteinase-1 PromotesMedicineTissue Inhibitor +8

A case of primordial odontogenic tumor: A new entity in the latest WHO classification (2017)

Toshinori Ando, Madhu Shrestha, Takashi Nakamoto, +6

Pathology International